Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Though AI-based systems have proven their worth when it comes to diagnosing various conditions from medical images, there’s still a need to prove the capabilities in a clinical setting, according to a recent invited commentary piece published in JAMA.
Digital pathology company Proscia raised $8.3 million in a Series A financing round to expand its artificial intelligence (AI) platforms for cancer diagnosis.
A graduate student at the University of British Columbia, in Vancouver, recently launched a mobile application that helps families and caregivers manage the care of senior citizens.
An artificial intelligence (AI)-based grading system successfully diagnosed two patients with diabetic retinopathy, according to a study published by JAMA.
Veterans and other individuals managing kidney disease are being asked to test a new nutrition-tracking mobile application designed to help kidney patients.
A research team with Washington State University in Pullman, Washington, has created a biofuel-powered sensor that runs on glucose and can be used to detect, prevent and diagnose diseases.
